Expert Highlights Incorporation of Neoadjuvant Endocrine Therapy Into ER+ Breast Cancer

Hung T. Khong, MD, discusses the benefits of neoadjuvant endocrine therapy and addresses the use of adjuvant endocrine therapy in ER-positive breast cancer.

More From BioPortfolio on "Expert Highlights Incorporation of Neoadjuvant Endocrine Therapy Into ER+ Breast Cancer"